In keeping with these prior biological observations, our analyses indicated that lead SNP rs3184504-C was associated with lower SH2B3 expression, reduced autoimmune disease (RA and SLE) and higher endometrial cancer risk. Here, SH2B3 is linked to endometrial cancer.